vs

Side-by-side financial comparison of ACADIA PHARMACEUTICALS INC (ACAD) and Heritage Insurance Holdings, Inc. (HRTG). Click either name above to swap in a different company.

ACADIA PHARMACEUTICALS INC is the larger business by last-quarter revenue ($268.1M vs $215.3M, roughly 1.2× Heritage Insurance Holdings, Inc.). Heritage Insurance Holdings, Inc. runs the higher net margin — 31.0% vs 1.4%, a 29.6% gap on every dollar of revenue. On growth, ACADIA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.7% vs 2.4%). Over the past eight quarters, Heritage Insurance Holdings, Inc.'s revenue compounded faster (6.1% CAGR vs 5.3%).

Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.

United Property & Casualty Insurance Company, Inc. is an American property and casualty insurance company with headquarters in Florida. It writes commercial, residential, homeowners’, and flood insurance policies in several coastal states.

ACAD vs HRTG — Head-to-Head

Bigger by revenue
ACAD
ACAD
1.2× larger
ACAD
$268.1M
$215.3M
HRTG
Growing faster (revenue YoY)
ACAD
ACAD
+7.3% gap
ACAD
9.7%
2.4%
HRTG
Higher net margin
HRTG
HRTG
29.6% more per $
HRTG
31.0%
1.4%
ACAD
Faster 2-yr revenue CAGR
HRTG
HRTG
Annualised
HRTG
6.1%
5.3%
ACAD

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ACAD
ACAD
HRTG
HRTG
Revenue
$268.1M
$215.3M
Net Profit
$3.6M
$66.7M
Gross Margin
Operating Margin
-1.7%
41.6%
Net Margin
1.4%
31.0%
Revenue YoY
9.7%
2.4%
Net Profit YoY
228.6%
EPS (diluted)
$0.02
$2.15

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACAD
ACAD
HRTG
HRTG
Q1 26
$268.1M
Q4 25
$284.0M
$215.3M
Q3 25
$278.6M
$212.5M
Q2 25
$264.6M
$208.0M
Q1 25
$244.3M
$211.5M
Q4 24
$259.6M
$210.3M
Q3 24
$250.4M
$211.8M
Q2 24
$242.0M
$203.6M
Net Profit
ACAD
ACAD
HRTG
HRTG
Q1 26
$3.6M
Q4 25
$273.6M
$66.7M
Q3 25
$71.8M
$50.4M
Q2 25
$26.7M
$48.0M
Q1 25
$19.0M
$30.5M
Q4 24
$143.7M
$20.3M
Q3 24
$32.8M
$8.2M
Q2 24
$33.4M
$18.9M
Gross Margin
ACAD
ACAD
HRTG
HRTG
Q1 26
Q4 25
90.8%
Q3 25
92.2%
Q2 25
92.2%
Q1 25
91.7%
Q4 24
91.6%
Q3 24
92.5%
Q2 24
92.5%
Operating Margin
ACAD
ACAD
HRTG
HRTG
Q1 26
-1.7%
Q4 25
6.1%
41.6%
Q3 25
12.8%
33.0%
Q2 25
12.2%
31.2%
Q1 25
7.9%
20.1%
Q4 24
59.1%
15.0%
Q3 24
12.6%
5.5%
Q2 24
12.6%
13.6%
Net Margin
ACAD
ACAD
HRTG
HRTG
Q1 26
1.4%
Q4 25
96.3%
31.0%
Q3 25
25.8%
23.7%
Q2 25
10.1%
23.1%
Q1 25
7.8%
14.4%
Q4 24
55.4%
9.7%
Q3 24
13.1%
3.8%
Q2 24
13.8%
9.3%
EPS (diluted)
ACAD
ACAD
HRTG
HRTG
Q1 26
$0.02
Q4 25
$1.61
$2.15
Q3 25
$0.42
$1.63
Q2 25
$0.16
$1.55
Q1 25
$0.11
$0.99
Q4 24
$0.86
$0.66
Q3 24
$0.20
$0.27
Q2 24
$0.20
$0.61

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACAD
ACAD
HRTG
HRTG
Cash + ST InvestmentsLiquidity on hand
$559.3M
Total DebtLower is stronger
$78.4M
Stockholders' EquityBook value
$505.3M
Total Assets
$1.6B
$2.2B
Debt / EquityLower = less leverage
0.16×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACAD
ACAD
HRTG
HRTG
Q1 26
Q4 25
$177.7M
$559.3M
Q3 25
$258.0M
$560.4M
Q2 25
$253.6M
$473.5M
Q1 25
$217.7M
$425.9M
Q4 24
$319.6M
$452.7M
Q3 24
$155.1M
$509.9M
Q2 24
$177.1M
$480.9M
Total Debt
ACAD
ACAD
HRTG
HRTG
Q1 26
Q4 25
$78.4M
Q3 25
$79.3M
Q2 25
$92.4M
Q1 25
$94.8M
Q4 24
$116.3M
Q3 24
$118.6M
Q2 24
$120.8M
Stockholders' Equity
ACAD
ACAD
HRTG
HRTG
Q1 26
Q4 25
$1.2B
$505.3M
Q3 25
$917.3M
$437.3M
Q2 25
$822.4M
$383.3M
Q1 25
$765.2M
$329.0M
Q4 24
$732.8M
$290.8M
Q3 24
$577.2M
$279.3M
Q2 24
$516.7M
$255.3M
Total Assets
ACAD
ACAD
HRTG
HRTG
Q1 26
$1.6B
Q4 25
$1.6B
$2.2B
Q3 25
$1.3B
$2.4B
Q2 25
$1.2B
$2.5B
Q1 25
$1.1B
$2.2B
Q4 24
$1.2B
$2.5B
Q3 24
$976.9M
$2.4B
Q2 24
$914.1M
$2.6B
Debt / Equity
ACAD
ACAD
HRTG
HRTG
Q1 26
Q4 25
0.16×
Q3 25
0.18×
Q2 25
0.24×
Q1 25
0.29×
Q4 24
0.40×
Q3 24
0.42×
Q2 24
0.47×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACAD
ACAD
HRTG
HRTG
Operating Cash FlowLast quarter
$182.2M
Free Cash FlowOCF − Capex
$174.2M
FCF MarginFCF / Revenue
80.9%
Capex IntensityCapex / Revenue
3.7%
Cash ConversionOCF / Net Profit
2.73×
TTM Free Cash FlowTrailing 4 quarters
$337.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACAD
ACAD
HRTG
HRTG
Q1 26
Q4 25
$-48.7M
$182.2M
Q3 25
$74.3M
$124.3M
Q2 25
$64.0M
$43.3M
Q1 25
$20.3M
$837.0K
Q4 24
$40.4M
$87.1M
Q3 24
$63.2M
$-13.4M
Q2 24
$25.0M
$152.2M
Free Cash Flow
ACAD
ACAD
HRTG
HRTG
Q1 26
Q4 25
$174.2M
Q3 25
$73.9M
$122.7M
Q2 25
$41.8M
Q1 25
$-1.3M
Q4 24
$78.9M
Q3 24
$63.2M
$-16.3M
Q2 24
$149.8M
FCF Margin
ACAD
ACAD
HRTG
HRTG
Q1 26
Q4 25
80.9%
Q3 25
26.5%
57.8%
Q2 25
20.1%
Q1 25
-0.6%
Q4 24
37.5%
Q3 24
25.2%
-7.7%
Q2 24
73.6%
Capex Intensity
ACAD
ACAD
HRTG
HRTG
Q1 26
Q4 25
3.7%
Q3 25
0.1%
0.7%
Q2 25
0.7%
Q1 25
1.0%
Q4 24
3.9%
Q3 24
0.0%
1.4%
Q2 24
1.2%
Cash Conversion
ACAD
ACAD
HRTG
HRTG
Q1 26
Q4 25
-0.18×
2.73×
Q3 25
1.03×
2.47×
Q2 25
2.40×
0.90×
Q1 25
1.07×
0.03×
Q4 24
0.28×
4.29×
Q3 24
1.93×
-1.64×
Q2 24
0.75×
8.07×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons